Patents Assigned to STELLA ApS
  • HCV Combination Therapy
    Publication number: 20140213632
    Abstract: The present invention relates to the treatment of hepatitis C (HCV) infection by the combination treatment with a miR-122 inhibitor and a HCV NS5A RNA protein inhibitor.
    Type: Application
    Filed: June 25, 2012
    Publication date: July 31, 2014
    Applicant: Stella Aps
    Inventor: Michael Hodges
  • HCV Combination Therapy
    Publication number: 20140127159
    Abstract: The present invention relates to the treatment of hepatitis C (HCV) infection by the combination treatment with a miR-122 inhibitor and a HCV NS3/4A protease inhibitor.
    Type: Application
    Filed: June 25, 2012
    Publication date: May 8, 2014
    Applicant: Stella ApS
    Inventor: Michael Hodges
  • HCV Combination Therapy
    Publication number: 20140113958
    Abstract: The present invention relates to the treatment of hepatitis C (HCV) infection by the combination treatment with a miR-122 inhibitor and a HCV NS5B RNA dependant RNA polymerase inhibitor.
    Type: Application
    Filed: June 25, 2012
    Publication date: April 24, 2014
    Applicant: STELLA ApS
    Inventor: Michael Hodges